MAHESH SEETHARAM, MD, FACP
Hematology & Oncology Physician · PHOENIX, AZ
Individual Active NPI 1487781175
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,009 | 166,511 | $19,687,926 | $4,807,590 | $3,824,977 |
| 2023 | 758 | 68,310 | $7,408,562 | $1,808,939 | $1,436,601 |
| 2022 | 728 | 63,557 | $7,088,593 | $1,804,104 | $1,437,311 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 18,002 | $56 | $45 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 16,200 | $49 | $39 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,200 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 7,164 | $0 | $0 |
| J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg | 7,000 | $35 | $29 |
| J9299 | Injection, nivolumab, 1 mg | 6,960 | $31 | $25 |
| J9025 | Injection, azacitidine, 1 mg | 5,190 | $0 | $0 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 4,860 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 4,500 | $0 | $0 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 3,900 | $14 | $11 |
| J0897 | Injection, denosumab, 1 mg | 2,340 | $26 | $20 |
| J9173 | Injection, durvalumab, 10 mg | 2,022 | $80 | $64 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 43047 | AZ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Arizona
- NPI 1558710475
- NPI 1417345919
- NPI 1487092094
- NPI 1629024955
- NPI 1083979132
- NPI 1518301019
- NPI 1134102536
- NPI 1851323547
See all Hematology & Oncology Physician providers in Arizona →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.